Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
暂无分享,去创建一个
[1] G. Sethi,et al. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy , 2023, Medicinal research reviews.
[2] M. Foti,et al. Endoplasmic Reticulum Stress in Renal Cell Carcinoma , 2023, International journal of molecular sciences.
[3] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[4] Yonghui Zhang,et al. Endoplasmic reticulum stress in melanoma pathogenesis and resistance. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Xuepeng Wang,et al. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy , 2022, Signal Transduction and Targeted Therapy.
[6] Hui Cao,et al. Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges , 2022, Frontiers in Pharmacology.
[7] G. Robertson,et al. Drug-tolerant persister cells in cancer therapy resistance. , 2022, Cancer research.
[8] L. Sequist,et al. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management , 2022, Nature Reviews Clinical Oncology.
[9] X. Xiong,et al. Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury , 2022, Frontiers in Cellular Neuroscience.
[10] Liying Hao,et al. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance , 2022, Cell Death & Disease.
[11] W.H. Tang,et al. Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells , 2022, International journal of biological sciences.
[12] Wanqing Chen,et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.
[13] F. Heindryckx,et al. Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma , 2022, Cells.
[14] Xinghuan Wang,et al. Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate , 2022, Cell death & disease.
[15] J. Fletcher,et al. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition. , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[16] Chuanbin Guo,et al. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells , 2021, BMC Cancer.
[17] Longfei Lin,et al. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019 , 2021, Journal of Hematology & Oncology.
[18] D. Ron,et al. Pharmacological targeting of endoplasmic reticulum stress in disease , 2021, Nature reviews. Drug discovery.
[19] Chen Liang,et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives , 2021, Molecular Cancer.
[20] Feilong Wei,et al. Sestrin2-Mediated Autophagy Contributes to Drug Resistance via Endoplasmic Reticulum Stress in Human Osteosarcoma , 2021, Frontiers in Cell and Developmental Biology.
[21] S. Klauck,et al. Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway. , 2021, Biochemical pharmacology.
[22] Yinglei Zhai,et al. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy , 2021, Acta pharmaceutica Sinica. B.
[23] Ruihua Xu,et al. Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 , 2021, Cancer communications.
[24] M. Ashrafizadeh,et al. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] Hongmei Zhou,et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer , 2021, Signal Transduction and Targeted Therapy.
[26] Yun Dai,et al. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer , 2021, Acta pharmaceutica Sinica. B.
[27] S. Kang,et al. Glutathione peroxidase-1 regulates ASK1-dependent apoptosis via interaction with TRAF2 in RIPK3-negative cancer cells , 2021, Experimental & Molecular Medicine.
[28] Hui Cao,et al. Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link , 2021, Frontiers in Cell and Developmental Biology.
[29] Yongheng Chen,et al. Nanomaterials for cancer therapy: current progress and perspectives , 2021, Journal of Hematology & Oncology.
[30] Pei-Ming Yang,et al. PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells , 2021, International journal of molecular sciences.
[31] A. Mackiewicz,et al. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance , 2021, Frontiers in Immunology.
[32] Xiangxuan Zhao,et al. Targeting Bcl-2 for cancer therapy. , 2021, Biochimica et biophysica acta. Reviews on cancer.
[33] M. Schröder,et al. The Unfolded Protein Response: An Overview , 2021, Biology.
[34] Yong Li,et al. Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis , 2021, Redox biology.
[35] R. Huo,et al. Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers , 2021, Frontiers in Pharmacology.
[36] Haiyuan Zhang,et al. The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance , 2021, Frontiers in Molecular Biosciences.
[37] M. Ashrafizadeh,et al. Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance , 2021, Cancers.
[38] D. Bezerra,et al. Chloroquine and hydroxychloroquine in antitumor therapies based on related-autophagy mechanisms. , 2021, Pharmacological research.
[39] Qi Wang,et al. GRP78 in lung cancer , 2021, Journal of translational medicine.
[40] Jun Ren,et al. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases , 2021, Nature Reviews Cardiology.
[41] Youhui Wang,et al. JAK2/STAT3 inhibitor reduced 5-FU resistance and autophagy through ATF6-mediated ER stress , 2021, Journal of receptor and signal transduction research.
[42] C. Kundu,et al. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[43] C. Croce,et al. MicroRNA and ER stress in cancer. , 2021, Seminars in cancer biology.
[44] Xi Chen,et al. Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.
[45] N. Lou,et al. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma , 2020, Aging.
[46] K. M. Fazili,et al. The molecular mechanism and functional diversity of UPR signaling sensor IRE1. , 2020, Life sciences.
[47] Liwei Huang,et al. Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity , 2020, Frontiers in Cell and Developmental Biology.
[48] A. Lampis,et al. MicroRNAs as mediators of drug resistance mechanisms. , 2020, Current opinion in pharmacology.
[49] Maria Nicoletta Moretti,et al. GADD34 is a modulator of autophagy during starvation , 2020, Science Advances.
[50] Lei Xu,et al. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma , 2020, Acta pharmacologica Sinica.
[51] E. M. Martín del Valle,et al. Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine , 2020, Nanomaterials.
[52] T. Yevsa,et al. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.
[53] Yun-Ru Liu,et al. Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells , 2020, Marine drugs.
[54] Tianzhi Huang,et al. Stem cell programs in cancer initiation, progression, and therapy resistance , 2020, Theranostics.
[55] T. Spicer,et al. Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming , 2020, Nature Chemical Biology.
[56] C. Hetz,et al. Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.
[57] Prabhanjan S. Giram,et al. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer. , 2020, Materials science & engineering. C, Materials for biological applications.
[58] Mateusz Kciuk,et al. Mechanisms of Multidrug Resistance in Cancer Chemotherapy , 2020, International journal of molecular sciences.
[59] J. Cheong,et al. PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells , 2020, Journal of experimental & clinical cancer research : CR.
[60] Shi‐Mei Zhuang,et al. LncRNA GOLGA2P10 is induced by PERK/ATF4/CHOP signaling and protects tumor cells from ER stress-induced apoptosis by regulating Bcl-2 family members , 2020, Cell Death & Disease.
[61] Junia C Costa,et al. Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition , 2020, International journal of molecular sciences.
[62] Jinliang Hu,et al. Activating transcription factor 6 regulated cell growth, migration and inhibiteds cell apoptosis and autophagy via MAPK pathway in cervical cancer. , 2020, Journal of reproductive immunology.
[63] S. Oakes,et al. Endoplasmic Reticulum Stress Signaling in Cancer Cells. , 2020, The American journal of pathology.
[64] Ian H. Guldner,et al. Cell surface GRP78 promotes stemness in normal and neoplastic cells , 2020, Scientific Reports.
[65] Q. Gao,et al. IRE1α-targeting Downregulates ABC Transporters and Overcomes Drug Resistance of Colon Cancer Cells. , 2020, Cancer letters.
[66] Hui Liu,et al. miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78 , 2020, Frontiers in Oncology.
[67] Gong Yang,et al. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy , 2020, Cell Death & Disease.
[68] B. van de Water,et al. ATF6 Is a Critical Determinant of CHOP Dynamics during the Unfolded Protein Response , 2020, iScience.
[69] A. Sartori,et al. Harnessing DNA Double-Strand Break Repair for Cancer Treatment , 2019, Front. Oncol..
[70] Y. Assaraf,et al. Towards the overcoming of anticancer drug resistance mediated by p53 mutations. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[71] Chenlian Yang,et al. Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer. , 2019, Histology and histopathology.
[72] Neil Vasan,et al. A view on drug resistance in cancer , 2019, Nature.
[73] S. Kim,et al. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51 , 2019, Breast Cancer Research.
[74] Yuliang Li,et al. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway , 2019, Cell Death & Disease.
[75] Y. Assaraf,et al. The multi-factorial nature of clinical multidrug resistance in cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[76] S. Leng,et al. Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non–small‐cell lung cancer cells , 2019, Molecular carcinogenesis.
[77] Linfu Li,et al. Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells , 2019, Journal of Cancer.
[78] L. Galluzzi,et al. Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. , 2019, Trends in cell biology.
[79] Eduard Batlle,et al. Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.
[80] G. Stassi,et al. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance , 2019, Molecular Cancer.
[81] T. Bivona,et al. Polytherapy and Targeted Cancer Drug Resistance. , 2019, Trends in cancer.
[82] B. Durden,et al. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness” , 2019, Cell Death & Disease.
[83] Piyush B. Gupta,et al. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. , 2019, Cell stem cell.
[84] Yunbao Pan,et al. Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51. , 2019, Cellular signalling.
[85] Á. Somoza,et al. Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment , 2018, Cellular and Molecular Life Sciences.
[86] W. Dong,et al. Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[87] Tao Zhang,et al. Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. , 2018, Cancer letters.
[88] R. Amaravadi,et al. Targeting autophagy in cancer , 2018, Cancer.
[89] H. Yao,et al. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 , 2018, Nature Communications.
[90] M. Gottesman,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.
[91] R. Uzzo,et al. The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma , 2018, Cell Death & Disease.
[92] Ita Novita Sari,et al. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment , 2018, Stem cells international.
[93] A. Shaw,et al. Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.
[94] V. Sasidharan Nair,et al. Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells , 2018, Immunology and cell biology.
[95] J. Graf,et al. Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures , 2017, PloS one.
[96] H. Clevers,et al. Cancer stem cells revisited , 2017, Nature Medicine.
[97] Ryohei Katayama,et al. Therapeutic strategies and mechanisms of drug resistance in anaplastic lymphoma kinase (ALK)-rearranged lung cancer. , 2017, Pharmacology & therapeutics.
[98] Chiara Riganti,et al. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy , 2017, Molecular Cancer.
[99] R. Weinberg,et al. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.
[100] Ting Wu,et al. Tumor microenvironment and therapeutic response. , 2017, Cancer letters.
[101] N. McGranahan,et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.
[102] Juan R. Cubillos-Ruiz,et al. Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer , 2017, Cell.
[103] T. Fahey,et al. Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib , 2017, The Journal of clinical endocrinology and metabolism.
[104] Alberto Mantovani,et al. Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.
[105] D. Lambrechts,et al. Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response , 2016, Translational oncology.
[106] J. Joyce,et al. STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation. , 2016, Cell reports.
[107] J. Shim,et al. Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer , 2016, Molecules.
[108] C. Blanpain,et al. Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.
[109] J. Chen,et al. Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp. , 2016, Oncology reports.
[110] Peter Walter,et al. Translation from the 5′ untranslated region shapes the integrated stress response , 2016, Science.
[111] Yong Peng,et al. The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.
[112] E. Taylor,et al. Imiquimod‐induced apoptosis of melanoma cells is mediated by ER stress‐dependent Noxa induction and enhanced by NF‐κB inhibition , 2015, Journal of cellular and molecular medicine.
[113] Juan R. Cubillos-Ruiz,et al. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.
[114] T. Zhou,et al. RACK1 modulates apoptosis induced by sorafenib in HCC cells by interfering with the IRE1/XBP1 axis. , 2015, Oncology reports.
[115] G. Peters,et al. Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia , 2015, Journal of Hematology & Oncology.
[116] Gong Yang,et al. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. , 2015, Cancer letters.
[117] Philip Levy Ho,et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.
[118] J. Gustafsson,et al. ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway , 2014, Oncogene.
[119] A. Puisieux,et al. Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.
[120] Jai-Sing Yang,et al. The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin‐mediated cell death of human prostate cancer PC‐3 cells , 2014, Environmental toxicology.
[121] Eduard Batlle,et al. Metastatic stem cells: sources, niches, and vital pathways. , 2014, Cell stem cell.
[122] M. Herlyn,et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.
[123] H. Tseng,et al. Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress. , 2014, Cellular signalling.
[124] D. Klionsky,et al. An overview of autophagy: morphology, mechanism, and regulation. , 2014, Antioxidants & redox signaling.
[125] M. Hsiao,et al. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78 , 2013, Oncogene.
[126] J. Su,et al. Sinulariolide Induced Hepatocellular Carcinoma Apoptosis through Activation of Mitochondrial-Related Apoptotic and PERK/eIF2α/ATF4/CHOP Pathway , 2013, Molecules.
[127] D. Steindler,et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance , 2013, EMBO molecular medicine.
[128] Tae Min Kim,et al. Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[129] Amy S. Lee,et al. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies , 2013, Oncogene.
[130] U. Jaehde,et al. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells. , 2012, Journal of inorganic biochemistry.
[131] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.
[132] E. Hahn,et al. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. , 2012, International journal of oncology.
[133] Jun-ling Liu,et al. Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells , 2012, Journal of cellular biochemistry.
[134] K. Choi. Autophagy and cancer , 2012, Experimental & Molecular Medicine.
[135] S. Qiu,et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis , 2011, Autophagy.
[136] K. Nan,et al. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.
[137] Shengbing Huang,et al. The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.
[138] D. Ron,et al. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.
[139] Sandra Barth,et al. Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.
[140] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[141] P. Wei,et al. Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma , 2010, Annals of Surgical Oncology.
[142] Ying Tang,et al. Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis , 2009, The EMBO journal.
[143] P. Fagone,et al. ATF6α induces XBP1-independent expansion of the endoplasmic reticulum , 2009, Journal of Cell Science.
[144] M. Stratton,et al. The cancer genome , 2009, Nature.
[145] P. Hersey,et al. Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. , 2009, Carcinogenesis.
[146] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[147] Chao Zhang,et al. IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response , 2007, Science.
[148] Amy S. Lee,et al. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. , 2007, Cancer research.
[149] Zhaohui Xu,et al. The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response , 2006, Proceedings of the National Academy of Sciences.
[150] Amy S. Lee,et al. GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development , 2006, Molecular and Cellular Biology.
[151] Peter Walter,et al. On the mechanism of sensing unfolded protein in the endoplasmic reticulum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[152] H. Beug,et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.
[153] S. Gambhir,et al. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. , 2004, Human gene therapy.
[154] R. Eils,et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[155] Randal J. Kaufman,et al. Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.
[156] R. Kaufman. Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.
[157] Xi Chen,et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. , 2002, Developmental cell.
[158] H. McLeod,et al. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. , 2001, Biochemical pharmacology.
[159] P. N. Rao,et al. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.
[160] X. Chen,et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. , 2000, Molecular cell.
[161] Jeffrey M. Skerker,et al. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.
[162] D. Macer,et al. Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. , 1986, Journal of cell science.
[163] Xiao-dong Liu. Transporter-Mediated Drug-Drug Interactions and Their Significance. , 2019, Advances in experimental medicine and biology.
[164] P. Fisher,et al. Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer. , 2018, Advances in cancer research.
[165] A. Chaudhary,et al. Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[166] J. Shih,et al. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. , 2013, Cancer letters.
[167] V. Adam,et al. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. , 2012, Pharmacology & therapeutics.